Agenus
AGEN | NASDAQ
$6.29
-$0.44 (-6.54%)
At close: Nov 16, 2026, 4:00 PM ET
$6.35
+$0.06 (+0.95%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-6.54%
(1D)Rating
65
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #90/1021 (Top 9%)
Key Statistics
Market Data
Market Cap $394.06M
1D Range
6.25 6.60
52W Range
2.77 9.93
Valuation (TTM)
PE 14.02
PB 45.33
EV/EBITDA 3.97
Valuation (NTM)
Forward PE 10.68
Forward PEG -0.05
Price Target $25.00
Cash Flow
FCF Yield -26.4%
SBC Adj. FCF Yield -29.2%
SBC Impact -10.7%
Margins
Gross Margin 100.0%
Operating Margin 38.9%
FCF Margin -77.5%
Growth (CAGR)
Revenue 3Y | 5Y 9.9% |
-15.3%
Dil EPS 3Y | 5Y 140.9% |
55.4%
FCF 3Y | 5Y 27.6% |
21.7%
Returns
ROA 12.6%
ROE -15.5%
ROIC 108.3%
Financial Health
Net Cash
$48.42M
Current Ratio 0.73
Interest Coverage 0.86
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Agenus Inc. is a clinical-stage biotechnology firm operating globally, dedicated to the discovery and development of immuno-oncology therapies. The company's innovative technological arsenal includes ...
Sector Healthcare
Industry Biotechnology
Employees 81
IPO Date Feb 8, 2000
Website www.agenusbio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
$0.02
Beat +107.08%
YoY:
-98.97% REV
$31.5M
Beat +11.70%
YoY:
+4.18%Next Earnings
Mar 15, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$25.00
Upside
+297.46%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove AGEN